Upregulation of vitamin D-related genes in schizophrenic patients

Fateme Asadzadeh Manjili,1 Seyed Mehdi Kalantar,2 Shahram Arsang-Jang,3 Soudeh Ghafouri-Fard,4 Mohammad Taheri,4,5 Arezou Sayad4 1Department of Medical Genetics, Shahid Sadoughi University of Medical Sciences, Yazd, Iran; 2Reproductive and Genetic Unit, Recurrent Abortion Research Center, Yazd Repr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Asadzadeh Manjili F, Kalantar SM, Arsang-Jang S, Ghafouri-Fard S, Taheri M, Sayad A
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
VDR
Acceso en línea:https://doaj.org/article/4e0000c691684a25987fd214b445ea90
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4e0000c691684a25987fd214b445ea90
record_format dspace
spelling oai:doaj.org-article:4e0000c691684a25987fd214b445ea902021-12-02T04:38:35ZUpregulation of vitamin D-related genes in schizophrenic patients1178-2021https://doaj.org/article/4e0000c691684a25987fd214b445ea902018-10-01T00:00:00Zhttps://www.dovepress.com/upregulation-of-vitamin-d-related-genes-in-schizophrenic-patients-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Fateme Asadzadeh Manjili,1 Seyed Mehdi Kalantar,2 Shahram Arsang-Jang,3 Soudeh Ghafouri-Fard,4 Mohammad Taheri,4,5 Arezou Sayad4 1Department of Medical Genetics, Shahid Sadoughi University of Medical Sciences, Yazd, Iran; 2Reproductive and Genetic Unit, Recurrent Abortion Research Center, Yazd Reproductive Science Institute, Yazd University of Medical Sciences, Yazd, Iran; 3Clinical Research Development Center (CRDU), Qom University of Medical Sciences, Qom, Iran; 4Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 5Urogenital Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran Introduction: Low level of vitamin D is a potential risk factor for developing schizophrenia. Through interaction with its receptor (VDR) and the related enzymes (CYP27B1, CYP24A1), vitamin D modulates neurodevelopment, neuroprotection, and immunomodulation. Its deficiency leads to aberrant neurodevelopment in schizophrenic patients. Methods: In this case–control study, relative expression of VDR, CYP27B1, and CYP24A1 in schizophrenic patients was compared with healthy individuals. Total RNA was extracted from whole blood of 50 patients with schizophrenia and 50 healthy controls. Real-time PCR was used to determine relative gene expression levels of VDR, CYP27B1, and CYP24A1. Results: Significant upregulations were observed in VDR (P=0.004, 95% CI=0.77, 0.86), CYP27B1 (P=0.002, 95% CI=1.22, 4.98), and CYP24A1 (P≤0.0001, 95% CI=-2.721, 1.061) expressions in peripheral blood of schizophrenic patients compared with controls. Moreover, the gender-based analysis revealed upregulation of all genes in all the categories of male and female except for VDR gene in male group (P=0.234, 95% CI=-0.79, 3.35) and CYP27B1 gene in the female group (P=0.09, 95% CI=-0.21, 6.55). The age-based analysis demonstrated overexpression of VDR and CYP27B1 genes in all categories. Finally, there were significant correlations between expression levels of all genes (P<0.0001), while no correlation was found between age and expression of genes. Conclusion: We hypothesized that the observed upregulation of the mentioned genes in schizophrenia patients might be the result of a compensatory mechanism to protect the affected individuals against adverse consequences of this disorder. Such imbalance in vitamin D processing pathway might also be implicated in the pathogenesis of schizophrenia. However, future studies should be designed to confirm the results of the current study. Keywords: CYP27B1, CYP24A1, VDR, schizophreniaAsadzadeh Manjili FKalantar SMArsang-Jang SGhafouri-Fard STaheri MSayad ADove Medical PressarticleCYP27B1CYP24A1VDRschizophreniaNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 14, Pp 2583-2591 (2018)
institution DOAJ
collection DOAJ
language EN
topic CYP27B1
CYP24A1
VDR
schizophrenia
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle CYP27B1
CYP24A1
VDR
schizophrenia
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Asadzadeh Manjili F
Kalantar SM
Arsang-Jang S
Ghafouri-Fard S
Taheri M
Sayad A
Upregulation of vitamin D-related genes in schizophrenic patients
description Fateme Asadzadeh Manjili,1 Seyed Mehdi Kalantar,2 Shahram Arsang-Jang,3 Soudeh Ghafouri-Fard,4 Mohammad Taheri,4,5 Arezou Sayad4 1Department of Medical Genetics, Shahid Sadoughi University of Medical Sciences, Yazd, Iran; 2Reproductive and Genetic Unit, Recurrent Abortion Research Center, Yazd Reproductive Science Institute, Yazd University of Medical Sciences, Yazd, Iran; 3Clinical Research Development Center (CRDU), Qom University of Medical Sciences, Qom, Iran; 4Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 5Urogenital Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran Introduction: Low level of vitamin D is a potential risk factor for developing schizophrenia. Through interaction with its receptor (VDR) and the related enzymes (CYP27B1, CYP24A1), vitamin D modulates neurodevelopment, neuroprotection, and immunomodulation. Its deficiency leads to aberrant neurodevelopment in schizophrenic patients. Methods: In this case–control study, relative expression of VDR, CYP27B1, and CYP24A1 in schizophrenic patients was compared with healthy individuals. Total RNA was extracted from whole blood of 50 patients with schizophrenia and 50 healthy controls. Real-time PCR was used to determine relative gene expression levels of VDR, CYP27B1, and CYP24A1. Results: Significant upregulations were observed in VDR (P=0.004, 95% CI=0.77, 0.86), CYP27B1 (P=0.002, 95% CI=1.22, 4.98), and CYP24A1 (P≤0.0001, 95% CI=-2.721, 1.061) expressions in peripheral blood of schizophrenic patients compared with controls. Moreover, the gender-based analysis revealed upregulation of all genes in all the categories of male and female except for VDR gene in male group (P=0.234, 95% CI=-0.79, 3.35) and CYP27B1 gene in the female group (P=0.09, 95% CI=-0.21, 6.55). The age-based analysis demonstrated overexpression of VDR and CYP27B1 genes in all categories. Finally, there were significant correlations between expression levels of all genes (P<0.0001), while no correlation was found between age and expression of genes. Conclusion: We hypothesized that the observed upregulation of the mentioned genes in schizophrenia patients might be the result of a compensatory mechanism to protect the affected individuals against adverse consequences of this disorder. Such imbalance in vitamin D processing pathway might also be implicated in the pathogenesis of schizophrenia. However, future studies should be designed to confirm the results of the current study. Keywords: CYP27B1, CYP24A1, VDR, schizophrenia
format article
author Asadzadeh Manjili F
Kalantar SM
Arsang-Jang S
Ghafouri-Fard S
Taheri M
Sayad A
author_facet Asadzadeh Manjili F
Kalantar SM
Arsang-Jang S
Ghafouri-Fard S
Taheri M
Sayad A
author_sort Asadzadeh Manjili F
title Upregulation of vitamin D-related genes in schizophrenic patients
title_short Upregulation of vitamin D-related genes in schizophrenic patients
title_full Upregulation of vitamin D-related genes in schizophrenic patients
title_fullStr Upregulation of vitamin D-related genes in schizophrenic patients
title_full_unstemmed Upregulation of vitamin D-related genes in schizophrenic patients
title_sort upregulation of vitamin d-related genes in schizophrenic patients
publisher Dove Medical Press
publishDate 2018
url https://doaj.org/article/4e0000c691684a25987fd214b445ea90
work_keys_str_mv AT asadzadehmanjilif upregulationofvitamindrelatedgenesinschizophrenicpatients
AT kalantarsm upregulationofvitamindrelatedgenesinschizophrenicpatients
AT arsangjangs upregulationofvitamindrelatedgenesinschizophrenicpatients
AT ghafourifards upregulationofvitamindrelatedgenesinschizophrenicpatients
AT taherim upregulationofvitamindrelatedgenesinschizophrenicpatients
AT sayada upregulationofvitamindrelatedgenesinschizophrenicpatients
_version_ 1718401118568972288